Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Inclusion Criteria: * Seeking treatment for nasal obstruction and willing to undergo an office-based procedure * Nasal Obstruction Symptom Evaluation (NOSE) score of ≥ 60 at Baseline * Nasal valve is a primary or significant contributor to the subject's nasal obstruction as determined by the study investigator (based on clinical presentation, physical examination, nasal endoscopy, etc.) and the subject has a positive response to any of the following temporary measures (based on patient history or office exam): * Use of external nasal dilator strips (e.g., Breathe Right Strips) * Q-Tip test (manual intranasal lateralization) * Use of nasal stents * Cottle Maneuver (manual lateral retraction of the cheek) Exclusion Criteria: * Prior surgical treatment of the nasal valve * Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past twelve (12) months * Chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction * Septal deviation, turbinate hypertrophy, polyps, or ptotic nose tip believed to be a significant contributor to the subject's nasal obstruction symptoms * Known or suspected allergies or contraindications for any general or local anesthetic agents and / or any antibiotic medications * Known or suspected to be pregnant, or is lactating * Other medical conditions which in the opinion of the investigator could predispose the subject to poor wound healing or increased surgical risk